Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Ernexa Therapeutics - 34 Year Stock Price History | ERNA

Historical daily share price chart and data for Ernexa Therapeutics since 1991 adjusted for splits and dividends. The latest closing stock price for Ernexa Therapeutics as of July 18, 2025 is 1.98.
  • The all-time high Ernexa Therapeutics stock closing price was 333750.00 on June 23, 1993.
  • The Ernexa Therapeutics 52-week high stock price is 32.98, which is 1565.7% above the current share price.
  • The Ernexa Therapeutics 52-week low stock price is 1.75, which is 11.6% below the current share price.
  • The average Ernexa Therapeutics stock price for the last 52 weeks is 9.65.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Ernexa Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 3.7049 5.5500 9.6000 1.8200 1.9800 -54.48%
2024 23.4667 28.2000 37.0500 3.7500 4.3500 -83.89%
2023 39.9420 46.5000 75.9000 13.5000 27.0000 -44.10%
2022 307.6327 1452.0000 1452.0000 41.1000 48.3000 -96.14%
2021 3394.1071 1392.0000 23550.0000 1116.0000 1251.0000 -6.92%
2020 1127.0988 1338.0000 2700.0000 570.0000 1344.0000 1.82%
2019 1877.7857 1176.0000 2538.0000 1152.0000 1320.0000 12.82%
2018 2751.0837 2508.0000 4080.0000 1092.0000 1170.0000 -53.68%
2017 4053.8247 5400.0000 5724.0000 2256.0000 2526.0000 -50.47%
2016 4448.1429 4500.0000 6390.0000 2934.0000 5100.0000 6.25%
2015 9580.9524 12900.0000 17400.0000 4200.0000 4800.0000 -63.64%
2014 15475.0000 21600.0000 23700.0000 8700.0000 13200.0000 -30.16%
2013 11707.1429 6300.0000 25200.0000 5700.0000 18900.0000 200.00%
2012 6141.6000 8400.0000 8400.0000 3900.0000 6300.0000 -16.00%
2011 12744.0476 11700.0000 15600.0000 7500.0000 7500.0000 -34.21%
2010 13782.1429 13500.0000 21000.0000 9900.0000 11400.0000 -15.56%
2009 10972.6190 4200.0000 16800.0000 3900.0000 13500.0000 221.43%
2008 10375.4941 18000.0000 19200.0000 3300.0000 4200.0000 -77.42%
2007 31534.6614 41700.0000 47100.0000 14400.0000 18600.0000 -54.74%
2006 42829.4821 43800.0000 56700.0000 34800.0000 41100.0000 -8.05%
2005 64405.9524 92400.0000 107400.0000 36900.0000 44700.0000 -53.29%
2004 85813.0952 108300.0000 124500.0000 53100.0000 95700.0000 -13.78%
2003 66283.3333 33300.0000 118500.0000 28500.0000 111000.0000 208.33%
2002 30802.3810 25500.0000 49800.0000 21600.0000 36000.0000 33.33%
2001 22121.3710 18750.0000 36000.0000 13500.0000 27000.0000 44.00%
2000 81726.1905 112500.0000 195000.0000 16875.0000 18750.0000 -83.05%
1999 42827.3810 16875.0000 142500.0000 16875.0000 110625.0000 555.56%
1998 26882.4405 37500.0000 60000.0000 11250.0000 16875.0000 -43.75%
1997 91689.7233 114375.0000 142500.0000 30000.0000 30000.0000 -73.77%
1996 138594.9803 129375.0000 195000.0000 93750.0000 114375.0000 -15.28%
1995 159568.4524 176250.0000 247500.0000 123750.0000 135000.0000 -25.00%
1994 215297.6190 300000.0000 303750.0000 138750.0000 180000.0000 -40.00%
1993 254051.3834 161250.0000 333750.0000 142500.0000 300000.0000 102.53%
1992 107616.8799 93750.0000 172500.0000 63750.0000 148125.0000 58.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.015B $0.001B
Ernexa Therapeutics is developing cell therapies for the treatment of advanced cancer and autoimmune disease. Ernexa Therapeutics, formerly known as Eterna Therapeutics, is based in CAMBRIDGE, Mass.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $76.319B 28.63
Zoetis (ZTS) United States $66.158B 24.68
Takeda Pharmaceutical (TAK) Japan $45.915B 9.13
Daiichi Sankyo, - (DSNKY) Japan $45.464B 23.30
BeOne Medicines - (ONC) Cayman Islands $32.283B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.049B 0.00
Summit Therapeutics (SMMT) United States $19.458B 0.00
Merck (MKKGY) Germany $16.692B 12.23
Shionogi (SGIOY) Japan $14.207B 0.00
United Therapeutics (UTHR) United States $13.172B 11.65
Neurocrine Biosciences (NBIX) United States $13.065B 44.75
Orion OYJ (ORINY) Finland $10.973B 26.45
IPSEN (IPSEY) France $10.477B 0.00
Stevanato Group S.p.A (STVN) Italy $7.541B 46.11
Corcept Therapeutics (CORT) United States $7.514B 61.09
Madrigal Pharmaceuticals (MDGL) United States $7.419B 0.00
Grifols, S.A (GRFS) Spain $6.834B 0.00
Ionis Pharmaceuticals (IONS) United States $6.646B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.394B 0.00
Hypermarcas (HYPMY) Brazil $3.056B 20.10
Crinetics Pharmaceuticals (CRNX) United States $2.913B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.565B 8.99
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.498B 13.51
NewAmsterdam Pharma (NAMS) Netherlands $2.492B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.095B 0.00
Ocular Therapeutix (OCUL) United States $1.805B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.802B 0.00
ARS Pharmaceuticals (SPRY) United States $1.760B 0.00
Endo (NDOI) United States $1.606B 0.00
Evotec AG (EVO) Germany $1.513B 0.00
Harrow (HROW) United States $1.317B 0.00
Guardian Pharmacy Services (GRDN) United States $1.283B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.166B 23.32
Enliven Therapeutics (ELVN) United States $1.112B 0.00
Ardelyx (ARDX) United States $1.055B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.048B 0.00
Dyne Therapeutics (DYN) United States $1.025B 0.00
Akebia Therapeutics (AKBA) United States $1.014B 0.00
Collegium Pharmaceutical (COLL) United States $1.003B 5.41
Verve Therapeutics (VERV) United States $0.973B 0.00
ProKidney (PROK) United States $0.922B 0.00
Xeris Biopharma Holdings (XERS) United States $0.799B 0.00
Cronos Group (CRON) Canada $0.775B 0.00
KalVista Pharmaceuticals (KALV) United States $0.769B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.743B 0.00
Zevra Therapeutics (ZVRA) United States $0.660B 0.00
Xencor (XNCR) United States $0.638B 0.00
Relay Therapeutics (RLAY) United States $0.600B 0.00
Elite Pharmaceuticals (ELTP) United States $0.599B 0.00
USANA Health Sciences (USNA) United States $0.565B 12.29
Theravance Biopharma (TBPH) United States $0.563B 0.00
Organogenesis (ORGO) United States $0.554B 0.00
Oruka Therapeutics (ORKA) United States $0.544B 0.00
Bioventus (BVS) United States $0.514B 13.04
Tourmaline Bio (TRML) United States $0.475B 0.00
Siga Technologies (SIGA) United States $0.472B 9.87
Aquestive Therapeutics (AQST) United States $0.417B 0.00
Savara (SVRA) United States $0.391B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.345B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.336B 9.08
Altimmune (ALT) United States $0.331B 0.00
Aldeyra Therapeutics (ALDX) United States $0.323B 0.00
Nektar Therapeutics (NKTR) United States $0.309B 0.00
Heron Therapeutics (HRTX) United States $0.294B 0.00
AleAnna (ANNA) United States $0.292B 0.00
Nature's Sunshine Products (NATR) United States $0.275B 25.20
Nanobiotix S.A (NBTX) France $0.250B 0.00
OmniAb (OABI) United States $0.238B 0.00
Esperion Therapeutics (ESPR) United States $0.232B 0.00
MediWound (MDWD) Israel $0.221B 0.00
Larimar Therapeutics (LRMR) United States $0.206B 0.00
4D Molecular Therapeutics (FDMT) United States $0.195B 0.00
China SXT Pharmaceuticals (SXTC) China $0.191B 0.00
Galectin Therapeutics (GALT) United States $0.177B 0.00
Aclaris Therapeutics (ACRS) United States $0.174B 0.00
Profound Medical (PROF) Canada $0.170B 0.00
Journey Medical (DERM) United States $0.168B 0.00
Liminatus Pharma (LIMN) United States $0.141B 0.00
Lexeo Therapeutics (LXEO) United States $0.138B 0.00
Lyell Immunopharma (LYEL) United States $0.137B 0.00
Inhibikase Therapeutics (IKT) United States $0.137B 0.00
Avita Medical (RCEL) United States $0.137B 0.00
Korro Bio (KRRO) United States $0.128B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.124B 0.00
Protara Therapeutics (TARA) United States $0.119B 0.00
Champions Oncology (CSBR) United States $0.111B 18.20
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cassava Sciences (SAVA) United States $0.107B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.104B 0.00
VAXART, INC (VXRT) United States $0.101B 0.00
Cardiol Therapeutics (CRDL) Canada $0.098B 0.00
Achieve Life Sciences (ACHV) Canada $0.093B 0.00
Vivani Medical (VANI) United States $0.092B 0.00
Nutriband (NTRB) United States $0.090B 0.00
Fractyl Health (GUTS) United States $0.088B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Context Therapeutics (CNTX) United States $0.080B 0.00
Dominari Holdings (DOMH) United States $0.079B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.076B 0.00
Metagenomi (MGX) United States $0.074B 0.00
Surrozen (SRZN) United States $0.073B 0.00
Wellgistics Health (WGRX) United States $0.073B 0.00
Rafael Holdings (RFL) United States $0.072B 0.00
Pyxis Oncology (PYXS) United States $0.070B 0.00
PMV Pharmaceuticals (PMVP) United States $0.069B 0.00
Telomir Pharmaceuticals (TELO) United States $0.068B 0.00
Avalo Therapeutics (AVTX) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.064B 0.00
Inotiv (NOTV) United States $0.060B 0.00
Klotho Neurosciences (KLTO) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Unicycive Therapeutics (UNCY) United States $0.056B 0.00
ElectroCore (ECOR) United States $0.054B 0.00
Jupiter Neurosciences (JUNS) United States $0.054B 0.00
NRx Pharmaceuticals (NRXP) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 35.78
Gain Therapeutics (GANX) United States $0.048B 0.00
Prelude Therapeutics (PRLD) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
PolyPid (PYPD) Israel $0.037B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
Vivos Therapeutics (VVOS) United States $0.034B 0.00
Karyopharm Therapeutics (KPTI) United States $0.033B 0.00
FibroGen (FGEN) United States $0.031B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Scienture Holdings (SCNX) United States $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.019B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.019B 0.00
Relmada Therapeutics (RLMD) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Plus Therapeutics (PSTV) United States $0.019B 0.00
Incannex Healthcare (IXHL) Australia $0.018B 0.00
VYNE Therapeutics (VYNE) United States $0.018B 0.00
BioVie (BIVI) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
DURECT (DRRX) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.014B 2.43
TherapeuticsMD (TXMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Aptorum Group (APM) United Kingdom $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.36
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00